A Clinician's Guide to X-Linked Hypophosphatemia

被引:462
作者
Carpenter, Thomas O. [1 ,2 ]
Imel, Erik A. [3 ,4 ]
Holm, Ingrid A. [5 ,6 ,7 ]
de Beur, Suzanne M. Jan [8 ]
Insogna, Karl L. [9 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat Endocrinol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06520 USA
[3] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA
[4] Indiana Univ Sch Med, Dept Pediat Endocrinol, Indianapolis, IN USA
[5] Childrens Hosp, Program Genom, Div Genet, Boston, MA 02115 USA
[6] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Boston, MA USA
[8] Johns Hopkins Sch Med, Dept Med, Div Endocrinol, Baltimore, MD USA
[9] Yale Univ, Sch Med, Dept Internal Med Endocrinol, New Haven, CT USA
关键词
PHOSPHATE; FGF23; PHEX; RICKETS; OSTEOMALACIA; GROWTH-HORMONE TREATMENT; LONG-TERM TREATMENT; MINERAL METABOLISM; PHOSPHATE HOMEOSTASIS; RICKETS; CALCITRIOL; THERAPY; MUTATIONS; CHILDREN; GENE;
D O I
10.1002/jbmr.340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X-linked hypophosphatemia (XLH) is the prototypic disorder of renal phosphate wasting, and the most common form of heritable rickets. Physicians, patients, and support groups have all expressed concerns about the dearth of information about this disease and the lack of treatment guidelines, which frequently lead to missed diagnoses or mismanagement. This perspective addresses the recommendation by conferees for the dissemination of concise and accessible treatment guidelines for clinicians arising from the Advances in Rare Bone Diseases Scientific Conference held at the NIH in October 2008. We briefly review the clinical and pathophysiologic features of the disorder and offer this guide in response to the conference recommendation, based on our collective accumulated experience in the management of this complex disorder. (C) 2011 American Society for Bone and Mineral Research.
引用
收藏
页码:1381 / 1388
页数:8
相关论文
共 44 条
[1]   Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets [J].
Alon, Uri S. ;
Levy-Olomucki, Rachel ;
Moore, Wayne V. ;
Stubbs, Jason ;
Liu, Shiguang ;
Quarles, L. Darryl .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (03) :658-664
[2]  
Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]
[3]   Growth in X-linked hypophosphatemic rickets [J].
Ariceta, Gema ;
Langman, Craig B. .
EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (04) :303-309
[4]  
AURICCHIO A, 2008, ONLINE METABOLIC MOL, P1
[5]   Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice [J].
Beck, L ;
Soumounou, Y ;
Martel, J ;
Krishnamurthy, G ;
Gauthier, C ;
Goodyer, CG ;
Tenenhouse, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) :1200-1209
[6]  
Cameron FJ, 1999, CLIN ENDOCRINOL, V50, P577
[7]   New perspectives on the biology and treatment of X-linked hypophosphatemic rickets [J].
Carpenter, TO .
PEDIATRIC CLINICS OF NORTH AMERICA, 1997, 44 (02) :443-+
[8]  
CARPENTER TO, PRIMARY DISORDERS PH
[9]  
CHAN JCM, 1980, PEDIATRICS, V66, P445
[10]  
CHESNEY RW, 1983, PEDIATRICS, V71, P559